NCT01933932 2025-11-19
SELECT-1
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
Merck Sharp & Dohme LLC
Eli Lilly and Company
Wake Forest University Health Sciences
University of Alabama at Birmingham
Duke University
Radiation Therapy Oncology Group